Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation

Bioorg Med Chem. 2010 Jun 15;18(12):4433-40. doi: 10.1016/j.bmc.2010.04.074. Epub 2010 Apr 26.

Abstract

Phenazine 5,10-dioxides are prodrugs for antitumor therapy that undergo hypoxic-selective bioreduction to form cytotoxic species. Here we investigate the expanded system benzo[a]phenazine 7,12-dioxides as selective hypoxic cytotoxin-scaffold. The clonogenic survival of V79 cells on aerobic and anaerobic conditions, conduct us to study antiproliferative activity on Caco-2 tumoral cells in normoxia. Electrochemical, DNA-interaction and DNA-damage studies were performed to establish the mode of action. The results demonstrated the potential biological properties of the studied scaffold being derivatives 6-10 structural hits for further chemical-modifications to become into therapeutics for solid tumors. Compounds 6 and 8 with cytotoxicity against V79 cells in both conditions (aerobia and anaerobia) were also cytotoxic against Caco-2 tumoral cells in aerobiosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / therapeutic use
  • Caco-2 Cells
  • Cell Hypoxia / drug effects
  • Cell Line
  • Colonic Neoplasms / drug therapy
  • Cricetinae
  • DNA Damage
  • DNA Fragmentation
  • Humans
  • Phenazines / chemical synthesis
  • Phenazines / chemistry*
  • Phenazines / toxicity

Substances

  • Antineoplastic Agents
  • Phenazines